What Changed
Price Move History
- Daily moves over 5%
- 55 164 sessions, January 26, 2026 to September 18, 2026
- Largest daily move
- +55.6% close of February 9, 2026
Company Description
Reliance Global Group, Inc. is a Nasdaq-listed holding company that combines insurance agency operations, InsurTech platforms and strategic venture investments. The company has historically focused on acquiring, owning and actively managing wholesale and retail insurance agencies, with insurance commissions forming the core revenue model of its insurance operations. Reliance Global Group is incorporated in Florida and is headquartered in Lakewood, New Jersey.
The company’s operating foundation includes insurance and InsurTech activities built around independent insurance agencies and agency distribution. Its RELI Exchange platform is an InsurTech platform for independent insurance agencies. The platform is designed to support agency recruitment, customer acquisition and agent productivity through a centralized operating environment that includes pipeline stages, task management and communication tracking.
Reliance Global Group also operates EZRA International Group, a strategic growth platform focused on identifying, acquiring and building majority or controlling stakes in high-growth technology companies. The platform is intended to complement the company’s insurance business through active ownership and disciplined capital allocation across adjacent verticals. Recent company materials describe technology and life sciences as areas of focus within this ownership-driven model.
Within technology, Reliance has reported an equity position in Enquantum Ltd., a developer of post-quantum cryptographic solutions and quantum-resilient encryption technology for high-performance environments. The company has described its Enquantum investment as milestone-based, with ownership and governance participation increasing as defined technical and commercial milestones are met.
Within life sciences, Reliance formed LifeSci Global Group LLC, a Delaware limited liability company in which the company holds approximately 51% of the membership interests. LifeSci Global was formed to identify and make investments in healthcare-related companies. Its initial investment is in Innervate Radiopharmaceuticals LLC, a company focused on radiopharmaceutical products and related technologies. Innervate’s lead asset, 18F-mFBG, is being developed as a PET imaging agent for neuroblastoma.
The company’s public-company profile therefore reflects a dual operating structure: an insurance and InsurTech base centered on agency distribution, and a strategic ventures platform centered on ownership positions in technology and healthcare-related businesses. Reliance Global Group’s common stock trades on Nasdaq under the symbol EZRA.
Stock Performance
Reliance Global Group (EZRA) closed at $2.62 on September 18, 2026. Over the past month, the price has gained 13.4%.
EZRA Metrics & Rankings
Price returns through September 18, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Reliance Global Group has 10 recent news articles, with the latest published 7 days ago. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, AI, conferences, earnings date, crypto. View all EZRA news →
SEC Filings
Reliance Global Group has filed 10 recent SEC filings, including 8 Form 4, 2 Form 8-K. The most recent filing was submitted on September 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all EZRA SEC filings →
Insider Radar
Insider selling at Reliance Global Group over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
Reliance Global Group generated $12.4M in revenue in FY2025, operating income reached -$9.0M (-72.5% operating margin), and net income was -$7.0M, reflecting a -56.2% net profit margin. Diluted earnings per share stood at -$1.28. The company generated -$3.1M in operating cash flow. With a current ratio of 1.78, the balance sheet reflects a strong liquidity position.
Upcoming Events
Earnout measurement date
Rights Plan Expiration
Warrants expiration
Escrow release payment
Reliance Global Group has 4 upcoming scheduled events. The next event, "Earnout measurement date", is scheduled for August 31, 2027 (in 343 days). 3 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the EZRA stock price.
Short Interest History
Short interest in Reliance Global Group (EZRA) currently stands at 51.7 thousand shares, down 30.9% from the previous reporting period, representing 3.8% of the float. Since January 2026, short interest has decreased by 92.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Reliance Global Group (EZRA) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
EZRA Company Profile & Sector Positioning
Reliance Global Group (EZRA) operates in the Insurance Brokers industry within the broader Financial Services sector and is listed on the NASDAQ.